REVOLUTION MEDICINES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.33 USD | +0.42% |
|
+1.00% | +33.65% |
| 09/05 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
| 08/05 | Revolution Medicines Q1 Net Loss Narrows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES, INC. | Other Biotechnology & Medical Research | +0.42% | +1.00% | +33.65% | +52.10% | - | 6.32B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RVMD Stock
- Charts Revolution Medicines, Inc.
- Comparison Chart
